64 resultater (0,37070 sekunder)

Mærke

Butik

Pris (EUR)

Nulstil filter

Produkter
Fra
Butikker

Rapid Expert Consultations on the COVID-19 Pandemic - Engineering National Academies Of Sciences - Bog - National Academies Press - Plusbog.dk

Rapid Expert Consultations on the COVID-19 Pandemic - Engineering National Academies Of Sciences - Bog - National Academies Press - Plusbog.dk

In response to a request from the Office of Science and Technology Policy and the Office of the Assistant Secretary for Preparedness and Response, the National Academies of Sciences, Engineering, and Medicine convened a standing committee of experts to help inform the federal government on critical science and policy issues related to emerging infectious diseases and other 21st century health threats. This set of Rapid Expert Consultations are the first of their kind and represent the best evidence available to the Committee at the time each publication was released. The science on these issues is continually evolving, and the scientific consensus the Committee reaches on these topics will likely evolve with it. The standing committee includes members with expertise in emerging infectious diseases, public health, public health preparedness and response, biological sciences, clinical care and crisis standards of care, risk communication, and regulatory issues. Table of ContentsFront MatterRapid Expert Consultation on Severe Illness in Young Adults for the COVID-19 Pandemic (March 14, 2020)Rapid Expert Consultation on SARS-CoV-2 Surface Stability and Incubation for the COVID-19 Pandemic (March 15, 2020)Rapid Expert Consultation on Social Distancing for the COVID-19 Pandemic (March 19, 2020)Rapid Expert Consultation on Data Elements and Systems Design for Modeling and Decision Making for the COVID-19 Pandemic (March 21, 2020)Rapid Expert Consultation Update on SARS-CoV-2 Surface Stability and Incubation for the COVID-19 Pandemic (March 27, 2020)Rapid Expert Consultation on Crisis Standards of Care for the COVID-19 Pandemic (March 28, 2020)Rapid Expert Consultation on the Possibility of Bioaerosol Spread of SARS-CoV-2 for the COVID-19 Pandemic (April 1, 2020)Rapid Expert Consultation on SARS-CoV-2 Survival in Relation to Temperature and Humidity and Potential for Seasonality for the COVID-19 Pandemic (April 7, 2020)Rapid Expert Consultation on SARS-CoV-2 Laboratory Testing for the COVID-19 Pandemic (April 8, 2020)Rapid Expert Consultation on the Effectiveness of Fabric Masks for the COVID-19 Pandemic (April 8, 2020)Rapid Expert Consultation on SARS-CoV-2Viral Shedding and Antibody Response forthe COVID-19 Pandemic (April 8, 2020)

DKK 266.00
1

Finding What Works in Health Care - Board On Health Care Services - Bog - National Academies Press - Plusbog.dk

Finding What Works in Health Care - Board On Health Care Services - Bog - National Academies Press - Plusbog.dk

Healthcare decision makers in search of reliable information that compares health interventions increasingly turn to systematic reviews for the best summary of the evidence. Systematic reviews identify, select, assess, and synthesize the findings of similar but separate studies, and can help clarify what is known and not known about the potential benefits and harms of drugs, devices, and other healthcare services. Systematic reviews can be helpful for clinicians who want to integrate research findings into their daily practices, for patients to make well-informed choices about their own care, for professional medical societies and other organizations that develop clinical practice guidelines. Too often systematic reviews are of uncertain or poor quality. There are no universally accepted standards for developing systematic reviews leading to variability in how conflicts of interest and biases are handled, how evidence is appraised, and the overall scientific rigor of the process. In Finding What Works in Health Care the Institute of Medicine (IOM) recommends 21 standards for developing high-quality systematic reviews of comparative effectiveness research. The standards address the entire systematic review process from the initial steps of formulating the topic and building the review team to producing a detailed final report that synthesizes what the evidence shows and where knowledge gaps remain. Finding What Works in Health Care also proposes a framework for improving the quality of the science underpinning systematic reviews. This book will serve as a vital resource for both sponsors and producers of systematic reviews of comparative effectiveness research. Table of ContentsFront MatterSummary1 Introduction2 Standards for Initiating a Systematic Review3 Standards for Finding and Assessing Individual Studies4 Standards for Synthesizing the Body of Evidence5 Standards for Reporting Systematic Reviews6 Improving the Quality of Systematic Reviews: Discussion, Conclusions, and RecommendationsAppendix A: Abbreviations and AcronymsAppendix B: GlossaryAppendix C: Workshop Agenda and Questions to PanelistsAppendix D: Expert Guidance for Chapter 2: Standards for Initiating a Systematic ReviewAppendix E: Expert Guidance for Chapter 3: Standards for Finding and Assessing Individual StudiesAppendix F: Expert Guidance for Chapter 4: Standards for Synthesizing the Body of EvidenceAppendix G: Expert Guidance for Chapter 5: Standards for Reporting Systemic ReviewsAppendix H: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) ChecklistAppendix I: Committee Biographies

DKK 377.00
1

Developing a Multidisciplinary and Multispecialty Workforce for Patients with Cancer, from Diagnosis to Survivorship - Board On Global Health - Bog -

Review of NASA's Evidence Reports on Human Health Risks - Health And Medicine Division - Bog - National Academies Press - Plusbog.dk

Monitoring International Labor Standards - Division Of Behavioral And Social Sciences And Education - Bog - National Academies Press - Plusbog.dk

Effective Care for High-Need Patients - National Academy Of Medicine - Bog - National Academies Press - Plusbog.dk

Acute Exposure Guideline Levels for Selected Airborne Chemicals - Committee On Acute Exposure Guideline Levels - Bog - National Academies Press -

The Pervasive Role of Science, Technology, and Health in Foreign Policy - National Research Council - Bog - National Academies Press - Plusbog.dk

Evaluating Federal Research Programs - National Academy Of Sciences - Bog - National Academies Press - Plusbog.dk

Public Health Lessons for Non-Vaccine Influenza Interventions - National Academy Of Medicine - Bog - National Academies Press - Plusbog.dk

Acute Exposure Guideline Levels for Selected Airborne Chemicals - Committee On Toxicology - Bog - National Academies Press - Plusbog.dk

Strategies for a BEA Satellite Health Care Account - Division Of Behavioral And Social Sciences And Education - Bog - National Academies Press -

Imagining the Future of Undergraduate STEM Education - National Academy Of Engineering - Bog - National Academies Press - Plusbog.dk

Review of NASA's Evidence Reports on Human Health Risks - Institute Of Medicine - Bog - National Academies Press - Plusbog.dk

Realizing the Promise of Equity in the Organ Transplantation System - Cost Effective Committee On A Fairer And More Equitable - Bog - National

Realizing the Promise of Equity in the Organ Transplantation System - Cost Effective Committee On A Fairer And More Equitable - Bog - National

Each year, the individuals and organizations in the U.S. organ donation, procurement, allocation, and distribution system work together to provide transplants to many thousands of people, but thousands more die before getting a transplant due to the ongoing shortage of deceased donor organs and inequitable access to transplant waiting lists. Realizing the Promise of Equity in the Organ Transplantation System, a new consensus study report from the National Academies of Sciences, Engineering, and Medicine's Committee on A Fairer and More Equitable, Cost-Effective, and Transparent System of Donor Organ Procurement, Allocation, and Distribution, provides expert recommendations to improve fairness, equity, transparency, and cost-effectiveness in the donor organ system. Table of ContentsFront MatterSummary1 Introduction and Study Context2 The U.S. Organ Transplantation System and Opportunities for Improvement3 Foundations for a Trustworthy Deceased Donor Organ Transplantation System4 Confronting and Eliminating Inequities in the Organ Transplantation System5 Saving More Lives and Enhancing Equity with Deceased Donor Organ Allocation Policies6 Improving Procurement, Acceptance, and Use of Deceased Donor Organs7 Measuring and Improving System PerformanceAppendix A: Public Meeting AgendasAppendix B: IOM and National Academies Solid Organ Transplantation ReportsAppendix C: Biographical Sketches of Committee Members and Staff

DKK 370.00
1

Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System - Forum On Neuroscience And Nervous System Disorders - Bog -

Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System - Forum On Neuroscience And Nervous System Disorders - Bog -

Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, currently exist for measuring glutamate pathology in CNS disorders or injuries. Glutamate dysfunction has been associated with an extensive range of nervous system diseases and disorders. Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer's, substance abuse, and traumatic brain injury. These conditions are widespread, affecting a large portion of the United States population, and remain difficult to treat. Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers. The Institute of Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop on June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary investigates promising current and emerging technologies, and outlines strategies to procure resources and tools to advance drug development for associated nervous system disorders. Moreover, this report highlights presentations by expert panelists, and the open panel discussions that occurred during the workshop.

DKK 169.00
1

Review of NASA's Evidence Reports on Human Health Risks - Institute Of Medicine - Bog - National Academies Press - Plusbog.dk

Peer Review in the Department of Energy-Office of Science and Technology - National Research Council - Bog - National Academies Press - Plusbog.dk

Peer Review in the Department of Energy-Office of Science and Technology - National Research Council - Bog - National Academies Press - Plusbog.dk

The Office of Science and Technology (OST) of the U.S. Department of Energy's (DOE's) Office of Environmental Management (EM) recently has instituted a peer review program that uses the American Society of Mechanical Engineers (ASME), with administrative and technical support provided by the Institute for Regulatory Science (RSI), to conduct peer reviews of technologies (or groups of technologies) at various stages of development. OST asked the NRC to convene an expert committee to evaluate the effectiveness of its new peer review program and to make specific recommendations to improve the program, if appropriate. This is the first of two reports to be prepared by this committee on OST's new peer review program. OST requested this interim report to provide a preliminary assessment of OST's new peer review program. In the final report, the committee will provide a more detailed assessment of OST's peer review program after its first complete annual cycle. Table of ContentsFront MatterExecutive SummaryIntroductionDefinition of Peer ReviewBenefits of Peer ReviewPeer Review ProcessImplementation of the Peer Review ProgramReferencesAppendix A: Description of OST's Peer Review ProgramAppendix B: Description of OST's Technology Investment Decision ModelAppendix C: Description of OST's Review ProgramAppendix D: Biographical SketchesAppendix E: Acronyms

DKK 208.00
1

Ensuring an Effective Public Health Emergency Medical Countermeasures Enterprise - Health And Medicine Division - Bog - National Academies Press -

Ensuring an Effective Public Health Emergency Medical Countermeasures Enterprise - Health And Medicine Division - Bog - National Academies Press -

The U.S. medical countermeasures (MCMs) enterprise is interconnected, complex, and dynamic. It includes public and private entities that develop and manufacture new and existing MCMs, ensure procurement, storage, and distribution of MCMs, and administer, monitor, and evaluate MCMs. The interagency group known as the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) is the nation's sole coordinating body, responsible for ensuring end-to-end MCM preparedness and response. Ensuring an Effective Public Health Emergency Medical Countermeasures Enterprise provides recommendations from an expert committee for a re-envisioned PHEMCE. Four priority areas of improvement emerged from committee deliberations: (1) articulating PHEMCE's mission and role and explicating the principles guiding PHEMCE's operating principles and processes, (2) revising PHEMCE operations and processes, (3) collaborating more effectively with external public and private partners, and (4) navigating legal and policy issues. Table of ContentsFront MatterSummary1 Introduction2 Delivering on PHEMCE's Mission3 Ensuring That PHEMCE Decisions and Recommendations Are Defensible4 Engaging Nonfederal and Private-Sector Partners and Stakeholders in PHEMCE's Mission5 Legal and Policy Considerations Underlying PHEMCE Operations and ImplementationAppendix A: Study MethodsAppendix B: Committee and Staff BiosketchesAppendix C: Disclosure of Unavoidable Conflicts of Interest

DKK 240.00
1

Selected Heritable Disorders of Connective Tissue and Disability - Health And Medicine Division - Bog - National Academies Press - Plusbog.dk

Selected Heritable Disorders of Connective Tissue and Disability - Health And Medicine Division - Bog - National Academies Press - Plusbog.dk

Heritable disorders of connective tissue (HDCTs) are a diverse group of inherited genetic disorders and subtypes. Because connective tissue is found throughout the body, the impairments associated with HDCTs manifest in multiple body systems and may change or vary in severity throughout an affected individual's lifetime. In some cases, these impairments may be severe enough to qualify an eligible child or adult for monetary benefits through the U.S. Social Security Administration's (SSA's) Social Security Disability Insurance or Supplemental Security Income program. SSA asked the National Academies of Sciences, Engineering, and Medicine to convene an expert committee that would provide current information regarding the diagnosis, treatment, and prognosis of selected HDCTs, including Marfan syndrome and the Ehlers-Danlos syndromes, and the effect of the disorders and their treatment on functioning. The resulting report, Selected Heritable Disorders of Connective Tissue and Disability, presents the committee's findings and conclusions. Table of ContentsFront MatterSummary1 Introduction2 Overview of Hereditary Disorders of Connective Tissue3 Marfan Syndrome and Related Hereditary Aortopathies4 Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders5 Heritable Disorders of Connective Tissue and Effects on Function6 Overall ConclusionsAppendix A: Public Session AgendasAppendix B: Commissioned PaperAppendix C: Selected ResourcesAppendix D: Biographical Sketches of Committee Members

DKK 279.00
1

Emerging Issues in Hispanic Health - Center For Social And Economic Studies - Bog - National Academies Press - Plusbog.dk

DKK 305.00
1